Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients

Lupus

Volumn 24, Issue 8, 2015, Pages 816-821

  Pamuk, O N ^a   Onat, A M ^b   Donmez, S ^a   Mengus C ^c   Kisacik, B ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

health outcome measure; LupusQoL TR; quality of life; Systemic lupus erythematosus; validation

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONSTRUCT VALIDITY; CONTROLLED STUDY; CONVERGENT VALIDITY; DISCRIMINANT VALIDITY; DISEASE ACTIVITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; LUPUS QUALITY OF LIFE INDEX TURKISH VERSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PLANNING; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY; COMPLICATION; MIDDLE AGED; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TURKEY; VALIDATION STUDY;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TURKEY;

EID: 84930921910     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314565412     Document Type: Article

References (23)

1. Murphy G, Lisnevskaia L, Isenberg D. Systemic lupus erythematosus and other autoimmune rheumatic diseases: Challenges to treatment. Lancet. 2013 ; 382: 809-818
2. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age groups. Medicine (Baltimore). 2005 ; 84: 218-224
3. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during 10-year period: A comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003 ; 82: 299-308
4. Pamuk ON, Akbay FG, Dönmez S, Yilmaz N, Calayir GB, Yavuz S. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: Report from two centers. Lupus. 2013 ; 22: 1416-1424
5. McElhone K, Abbott J, Shelmerdine J, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Care Res. 2007 ; 57: 972-979
6. Kong KO, Ho HJ, Howe HS, et al. Cross-cultural adaptation of the systemic lupus erythematosus quality of life questionnaire into Chinese. Arthritis Care Res. 2007 ; 57: 980-985
7. Devilliers H, Amoura Z, Besancenot JF, et al. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012 ; 51: 1906-1915
8. Kaya A, Goker B, Cura ES, et al. Turkish lupusPRO: Cross-cultural validation study for lupus. Clin Rheumatol. 2014 ; 33: 1079-1084
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
10. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998 ; 51: 903-912
11. Kocyigit H, Aydemir O, Fisek G, Olmez N, Memis A. Klsa Form-36 (KF-36)'nln Türkçe versiyonunun güvenilirliʇi ve geçerliliʇi. Zlac ve Tedavi Dergisi. 1999 ; 12: 102-106
12. Jolly M, Pickard AS, Wilke C, et al. Lupus-specific health outcome measure for US patients: The LupusQoL-US version. Ann Rheum Dis. 2010 ; 69: 29-33
13. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
14. Aday LA Designing and conducting health surveys. 2 nd ed. San Francisco, CA: Jossey-Bass, 1996. San Francisco, CA: Jossey-Bass ; 1996 :
15. Hays RD, Revicki D Assessing quality of life in clinical trials. Fayers P Hays R, ed. Oxford: Oxford University Press ; 2005: 25-39.
16. Kaiser HF. An index of factorial simplicity. Psychometrika. 1974 ; 39: 31-36
17. Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990 ; 107: 238-246
18. Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika. 1973 ; 38: 1-10
19. Steiger JH. Structural model evaluation and modification: An interval estimation approach. Multivar Behav Res. 1990 ; 25: 173-180
20. Alarcón GS, Calvo-Alen J, McGwin G, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006 ; 65: 1168-1174
21. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: I. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180
22. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predicts patients health related quality of life?. Lupus. 2004 ; 13: 924-926
23. Kuriya B, Gladman DD, Ibañez D, et al. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008 ; 59: 181-185